Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2012
09/11/2012US8263594 Aryloxy and arylalkyleneoxy substituted imidazoquinolines
09/11/2012US8263585 Organic compounds
09/11/2012CA2558506C Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
09/11/2012CA2551640C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
09/11/2012CA2543351C Amide derivatives
09/11/2012CA2508573C Novel coumarins, their carboxamide derivatives, preparation methods, compositions, and uses
09/07/2012WO2012119099A1 Compounds for porous films in light-emitting devices
09/07/2012WO2012118812A2 Substituted 6,5-fused bicyclic heteroaryl compounds
09/07/2012WO2012118715A2 Non-peptidic quenched fluorescent imaging probes
09/07/2012WO2012117996A1 Gpr119 agonist
09/07/2012WO2012117001A1 Novel benzodioxole piperidine compounds
09/07/2012WO2012117000A1 3-amino-pyridines as gpbar1 agonists
09/07/2012WO2012116440A1 Benzimidazole inhibitors of the sodium channel
09/07/2012WO2012116415A1 Novel small-molecules as therapeutics
09/07/2012CA2828780A1 Novel small-molecules as therapeutics
09/07/2012CA2828456A1 Benzimidazole inhibitors of the sodium channel
09/07/2012CA2827718A1 3-amino-pyridines as gpbar1 agonists
09/07/2012CA2823480A1 Novel benzodioxole piperidine compounds
09/06/2012US20120226046 Compounds for porous films in light-emitting devices
09/06/2012US20120226033 4-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases
09/06/2012US20120226031 Palmarumycin based inhibitors of thioredoxin and methods of using same
09/06/2012US20120225909 Indazole analog
09/06/2012US20120225896 Novel 2-pyridone derivative and pharmaceutical product containing same
09/06/2012US20120225892 [1,5]-Diazocin Derivatives
09/06/2012US20120225886 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
09/06/2012US20120225880 Pyrazole compounds and thiazole compounds as protein kinases inhibitors
09/06/2012US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/06/2012US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/06/2012US20120225874 Bicyclic derivatives as cetp inhibitors
09/06/2012US20120225873 Compounds for alzheimer's disease
09/06/2012US20120225872 Methods of preparing and using quinazoline and quinoline derivatives
09/06/2012US20120225871 Small-molecule modulators of trp-p8 activity
09/06/2012US20120225868 Novel benzodioxole piperidine compounds
09/06/2012US20120225867 Androgen receptor modulating compounds
09/06/2012US20120225863 Heterocyclic compounds for the inhibition of pask
09/06/2012US20120225861 6-O-Substituted Benzoxazole and Benzothiazole Compounds and Methods of Inhibiting CSF-1R Signaling
09/06/2012US20120225859 Pyrimidine derivatives used as pi-3 kinase inhibitors
09/06/2012US20120225857 Mst1 kinase inhibitors and methods of their use
09/06/2012US20120225854 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
09/06/2012US20120225847 Squaric acid derivatives as inhibitors of the nicotinamide
09/06/2012US20120225846 Heterocyclic compounds for the inhibition of pask
09/06/2012US20120225782 Pesticides
09/06/2012US20120225062 Novel kinase inhibitors
09/06/2012US20120225061 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
09/06/2012US20120223275 Substituted bipyridines for use in light-emitting devices
09/05/2012EP2495238A1 Novel 3-hydroxy-5-arylisoxazole derivative
09/05/2012EP2493949A1 Non-crystallising bis-oxazolidines
09/05/2012EP2493877A1 Pyrimidine compounds as delta opioid receptor modulators
09/05/2012EP2493876A1 Imidazole derivatives as casein kinase inhibitors
09/05/2012EP2493866A1 Tricyclic heterocyclic compounds
09/05/2012EP2493863A1 Phenoxy-substituted pyrimidines as opioid receptor modulators
09/05/2012EP2493862A1 Imidazole derivatives as ido inhibitors
09/05/2012EP2493858A1 Androgen receptor modulating compounds
09/05/2012EP2493856A1 Positive allosteric modulators (pam)
09/05/2012EP2493852A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
09/05/2012EP2493469A2 Pharmaceutical composition comprising indole compound
09/05/2012EP2493310A1 Benzimidazoles as fatty acid synthase inhibitors
09/05/2012EP2493308A1 Aryl aminopyridine pde10 inhibitors
09/05/2012CN1976922B 4-amino-5-cyanopyrimidine derivatives
09/05/2012CN1842521B Caspase inhibitors containing isoxazoline ring
09/05/2012CN102656168A Polycyclic compounds as lysophosphatidic acid receptor antagonists
09/05/2012CN102656167A Hiv integrase inhibitors
09/05/2012CN102656165A Glycoside derivatives and uses thereof
09/05/2012CN102656160A Benzimidazole analogues for the treatment or prevention of flavivirus infections
09/05/2012CN102656151A Substituted heterocyclic derivatives for the treatment of pain and epilepsy
09/05/2012CN102656149A Benzamide compound
09/05/2012CN102656148A Cyclic hydroxylamine derivatives, their preparation and use as antioxidants
09/05/2012CN102656147A Spiro indole-cyclopropane indolinones useful as AMPK modulators
09/05/2012CN102653511A 3,5-diaryl benzene ring ether derivate as well as preparation method and application thereof
09/05/2012CN101768155B Derivatives containing (aminomethyl-five-membered heterocyclo-4-carbonyl)-pyrrolidine-2-carboxylic acid, preparation method thereof and use thereof
09/05/2012CN101605771B 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
09/05/2012CN101589039B Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
09/05/2012CN101370799B Cis-4, 5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors
09/05/2012CN101300250B Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
09/04/2012US8258293 Tetrahydroquinoline derivatives
09/04/2012US8258161 Crystalline salt form of an antidiabetic compound
09/04/2012US8258152 N-substituted azaindoles and methods of use
09/04/2012US8258141 Organic compounds
09/04/2012US8258132 Pharmaceutical composition of a tachykinin receptor antagonist
09/04/2012US8258122 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
09/04/2012CA2656578C Tyrosine kinase inhibitors
09/04/2012CA2506716C Carboxamides
08/2012
08/30/2012WO2012115446A2 Compound based on 5-(substituted alkyl-aminomethyl) isoxazole acting as a t-type calcium channel antagonist
08/30/2012WO2012115177A1 N-[(biaryloxy)alkylcarbonyl]sulfonamide derivative
08/30/2012WO2012115097A1 Glycine transport inhibitor
08/30/2012WO2012114348A1 Novel compounds as histamine h3 receptor ligands
08/30/2012WO2012113850A2 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
08/30/2012WO2012113103A1 Asymmetric ureas and medical uses thereof
08/30/2012WO2012062901A3 Chromene derivatives and their analoga as wnt pathway antagonists
08/30/2012US20120220772 Novel 3-hydroxy-5-arylisoxazole derivative
08/30/2012US20120220769 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
08/30/2012US20120220622 Heterocyclic derivatives
08/30/2012US20120220616 Novel spiropiperidine compounds
08/30/2012US20120220611 1,3-benzoxazolyl derivatives as kinase inhibitors
08/30/2012US20120220591 Pyrimidone compounds
08/30/2012US20120220590 Novel compounds as modulators of glucocorticoid receptors
08/30/2012US20120220589 Heterocyclic compounds for the inhibition of pask
08/30/2012US20120220584 Heterocyclic compounds and methods of use
08/30/2012US20120220580 Preparation of carotenoid derivatives and their applications
08/30/2012US20120220568 Histamine-3 Receptor Antagonists
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 647